ADA 2011: Ranibizumab Improves Visual Acuity in Patients with Diabetic Macular Edema
More patients in the RIDE and RISE trials treated with the VEGF inhibitor showed improvements in vision test scores compared to patients who received placebo.
Read More
ADA 2011: Lifestyle Modifications vs. Medical Treatment in Diabetes Care
Treatment with metformin and diet and lifestyle modifications both are cost-effective means of decreasing diabetes risk and improving quality of life.
ADA 2011: New Developments in the Treatment of Type 1 Diabetes
Researchers are investigating novel ways to preserve beta cell function in type 1 diabetes patients and enhance the body's ability to produce its own insulin.
ADA 2011: Pharmacologic Options for Weight Management in Diabetic Patients
Researchers are investigating a variety of targets and pathways in the search for an effective weight-loss drug.
ADA 2011: Blood Glucose Self-monitoring Reduces Risk of CV Disease in Patients with Diabetes
Structured self-monitoring of blood glucose may result in lower levels of a key marker of cardiovascular disease risk in patient with type 2 diabetes.
ADA 2011: Solving the Challenge of Medication Adherence in Patients with Diabetes
Nonadherent patients with diabetes face severely increased risks of hospitalization and death.
ADA 2011: Assessment of Glycemic Variability and CD40 Ligand in the STAR 3 Study
Patients treated with sensor-augmented pump therapy may achieve lower glycemic variability than patients given multiple daily insulin injections.
ADA 2011: Dynamic Visual Representation of Key Data Helps Eliminate Hypoglycemia in the ICU
Real-time blood sugar and insulin infusion data displayed in the electronic medical record allows physicians to tailor treatment and get more patients to goal.
ADA 2011: Combo Treatment Increases Proportion of Diabetes Patients Achieving A1C Target
LEAD-6 trial results show improved glycemic control with weight loss and a low risk of hypoglycemia with liraglutide and exenatide.
ADA 2011: ADA, CDC Launch Beacon Communities Mobile Health IT Campaign
New program utilizes mobile technology to improve diabetes prevention and management.
ADA 2011: Novel SGLT2 Inhibitor Improves Glycemic Control in Patients with Diabetes
Japanese trial of TS-071 shows promise in weight loss and HbA1c reduction.
ADA 2011: Overcoming Barriers to Deliver Smart Geriatric Diabetes Care
There are several challenges to effective diabetes care that are specific to geriatric patients.
AACE 2011: Advances in Lipid Therapy and the Latest Practice Guidelines
Review of existing guidelines for cardiovascular disease and diabetes shows a continuing reliance on experience and expert opinion.
AACE 2011: The Latest on Pancreatic Islet Stem Cells and Diabetes Management
Enhancing beta cell regeneration and modulating autoimmune destruction of beta cells may be the key to effective diabetes treatment.
AACE 2011: Calcium, Vitamin D, and the Heart
Use a combination of recommendations and clinical judgment to determine the proper calcium and vitamin D requirements for each patient.
AACE 2011: Advances and Guidelines for Management of Hypertension in Diabetes
Clinical trial results used to support the current recommendations for target blood pressure don't tell the whole story.
AACE 2011: Environmental Disruptors to the Endocrine System
Presentation at AACE 2011 focuses on understanding environmental toxins and other disrupters to the endocrine system.
AACE 2011: Treating Insulin Resistance in Hypertension and Chronic Kidney Disease
George Bakris, MD, discusses combination therapies for treating hypertension, chronic kidney disease, and diabetes.
AACE 2011: How Genomics Will Drive Diabetes Prevention and Management
Eric Topol, MD, discusses pharmacogenetics, molecular medicine, genomics, and the future of diabetes treatment.
AACE 2011: New Ways to Tackle Less Common Cancers (and Take Them Out)
Daniel Von Hoff, MD, discussed novel treatments for rare cancers at the AACE annual meeting.
AACE 2011: New Agents for the Treatment of Diabetes
Research shows promising results for PPAR modulators, long-acting GLP-1 receptor agonists, SGLT2 inhibitors, and other new classes of diabetes treatments.
AACE 2011: Endocrinology, Critical Illness, and Clinical Trials: Perils and Pitfalls
Poorly designed trials evaluating hormonal control in critically ill patients may lead to erroneous conclusions with serious consequences for patients.
AACE 2011: Personalizing Cancer Therapy Based on Molecular Markers and Models
Molecular medicine is the future of cancer treatment, but also has many potential applications in endocrinology.